Integrating prevention interventions for people living with HIV into care and treatment programs: A systematic review of the evidence

Journal of Acquired Immune Deficiency Syndromes

Volumn 68, Issue , 2015, Pages S286-S296

  Medley, Amy ^a   Bachanas, Pamela ^a   Grillo, Michael ^b   Hasen, Nina ^c   Amanyeiwe, Ugochukwu ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c U S DEPARTMENT OF STATE   (United States)

^d UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

Author keywords

HIV prevention; HIV AIDS; people living with HIV; positive health, dignity, and prevention; resource limited settings

Indexed keywords

BIBLIOGRAPHIC DATABASE; CONDOM USE; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE TRANSMISSION; FAMILY PLANNING; FOLLOW UP; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROGRAM; HIV TEST; HOSPITALIZATION COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; MORBIDITY; PATIENT COMPLIANCE; PATIENT COUNSELING; PREGNANT WOMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; RISK REDUCTION; SOCIAL SUPPORT; SOUTH AFRICA; SYSTEMATIC REVIEW; ADULT; COST BENEFIT ANALYSIS; COUNSELING; DEVELOPING COUNTRY; ECONOMICS; HEALTH CARE PLANNING; HEALTH IMPACT ASSESSMENT; HIV INFECTIONS; OUTCOME ASSESSMENT; SEXUAL EDUCATION; SEXUALITY;

ADULT; COST-BENEFIT ANALYSIS; COUNSELING; DEVELOPING COUNTRIES; HEALTH IMPACT ASSESSMENT; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RISK REDUCTION BEHAVIOR; SEX EDUCATION; SEXUAL PARTNERS;

EID: 84929087489     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000520     Document Type: Review

References (109)

1. World Health Organization. Global Update on the Health Sector Response to HIV, 2014. Geneva, Switzerland. 2014. Available at: http://apps.who.int/iris/bitstream/10665/128494/1/9789241507585- eng.pdf?ua=1
2. Joint Programme on HIV/AIDS (UNAIDS) and the Global Network of People Living with HIV (GNP+). Positive Health, Dignity and Prevention: Operational Guidelines. Geneva, Switzerland. 2013. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/20130802-Positive-Health-Dignity-Prevention- Operational-Guidelines.pdf
3. President's Emergency Plan for AIDS Relief (PEPFAR). Guidance for the Prevention of Sexually Transmitted HIV Infections.Washington DC, 2011. Available at: http://www.pepfar.gov/documents/organization/171303.pdf
4. World Health Organization (WHO). Essential Prevention and Care Interventions for Adults and Adolescents Living with HIV in Resource- Limited Settings. Geneva, Switzerland. 2008. Available at: http://www. who.int/hiv/pub/guidelines/EP/en/index.html
5. Crepaz N, Lyles CM, Wolitski RJ., et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A metaanalytic review of controlled trials. AIDS. 2006;20:143-157
6. Myers J, Shade S, Rose C., et al. Interventions delivered in clinical settings are effective in reducing risk of HIV transmission among people living with HIV: results from the Health Resources and Services Administration (HRSA)'s Special Projects of National Significance initiative. AIDS Behav. 2010;14:483-492
7. Kennedy C, Medley A, Sweat M., et al. Behavioural interventions for HIV-positive prevention in developing countries: a systematic review and meta-analysis. Bull World Health Organ. 2010;88:615-623
8. Kaplan JE, Hamm TE, Forhan S., et al. The impact of HIV care and support interventions on key outcomes in low and middle-income countries: a literature review-introduction. J Acquir Immune Defic Syndr. 2015
9. Nachega JB, Chaisson RE, Goliath R., et al. Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy. AIDS. 2010;24:1273-1280
10. Taiwo BO, Idoko JA, Welty LJ., et al. Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting. J Acquir Immune Defic Syndr. 2010;54: 85-92
11. Cantrell RA, Sinkala M, Megazinni K., et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. JAIDS. 2008;49:190-195
12. Chang LW, Kagaayi J, Nakigozi G., et al. Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial. PLoS One. 2010;5:e10923
13. Chung MH, Richardson BA, Tapia K., et al. A randomized controlled trial comparing the effects of counselling and alarm device on HAART adherence and virologic outcomes. PLoS Med. 2011;8:e1000422
14. Idoko JA, Agbaji O, Agaba P., et al. Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effective. Int J STD AIDS. 2007; 18:760-763
15. Khachani I, Harmouche H, Ammouri W., et al. Impact of a psychoeducative intervention on adherence to HAART among low-literacy patients in a resource-limited setting: the case of an Arab country - Morocco. J Int Assoc Physicians AIDS Care (Chic). 2012;11:47-56
16. Kunutsor S, Walley J, Muchuro S., et al. Improving adherence to antiretroviral therapy in sub-Saharan African HIV-positive populations: an enhanced adherence package. AIDS Care. 2012;24:1308-1315
17. Lester RT, Ritvo R, Mills E., et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376:1838-1845
18. Mbuagbaw L, Thabane L, Ongolo-Zogo P., et al. The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One. 2012;7:e46909
19. Mugusi F, Mugusi S, Bakari M., et al. Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience. Trop Med Int Health. 2009;14:1226-1232
20. Muñoz M, Finnegan K, Zeladita J., et al. Community-based DOTHAART accompaniment in an urban resource-poor setting. AIDS Behav. 2010;14:721-730
21. Nyamathi A, Hanson AY, Salem BE., et al. Impact of a rural village women (Asha) intervention on adherence to antiretroviral therapy in southern India. Nurs Res. 2012;61:353-362
22. Pearson CR, Micek MA, Simoni JM., et al. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. JAIDS. 2007;46:238-244
23. Pop-Eleches C, Thirumurthy H, Habyarimana JP., et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25:825-834
24. Sabin LL, DeSilva MB, Hamer DH., et al. Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIVpositive patients in China. AIDS Behav. 2010;14:580-589
25. Sampaio-Sa M, Page-Shafer K, Bangsberg DR., et al. 100% adherence study: educational workshops vs. video sessions to improve adherence among ART-naive patients in Salvador, Brazil. AIDS Behav. 2008;12 (suppl 4):S54-S62
26. Sarna A, Luchters S, Geibel S., et al. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial. J Acquir Immune Defic Syndr. 2008;48:611-619
27. Siedner MJ, Lankowski A, Haberer JE., et al. Rethinking the Pre in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One. 2012; 7:e39894
28. Simoni JM, Chen WT, Huh D., et al. A preliminary randomized controlled trial of a nurse-delivered medication adherence intervention among HIV-positive outpatients initiating antiretroviral therapy in Beijing, China. AIDS Behav. 2011;15:919-929
29. Torpey K, Kabaso M, Mutale L., et al. Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health settings in Zambia. PLoS One. 2008;3:e2204
30. van Loggerenberg F, Grant AD, Naidoo K., et al. Individualised motivational counselling to enhance adherence to antiretroviral therapy is not superior to didactic counselling in South African patients: findings of the CAPRISA 058 randomised controlled trial. AIDS Behav. 2015;19 (1):145-56
31. Holstad MM, Essien JE, Ekong E., et al. Motivational groups support adherence to antiretroviral therapy and use of risk reduction behaviors in HIV positive Nigerian women: a pilot study. Afr J Reprod Health. 2012;16:14-27
32. Maman S, Moodley D, McNaughton-Reyes HL., et al. Efficacy of enhanced HIV counseling for risk reduction during pregnancy and in the postpartum period: a randomized control trial. PLoS One. 2014; 9:e97092
33. Saleh-Onoya D, Reddy P, Ruiter R., et al. Condom use promotion among isiXhosa speaking women living with HIV in the Western Cape Province, South Africa: a pilot study. AIDS Care. 2009;21:817-825
34. Futterman D, Shea J, Besser M., et al. Mamekhaya: a pilot study combining a cognitive-behavioral intervention and mentor mothers with PMTCT services in South Africa. AIDS Care. 2010;22:1093-1100
35. Olley BO. Improving well-being through psycho-education among voluntary counseling and testing seekers in Nigeria: a controlled outcome study. AIDS Care. 2006;18:1025-1031
36. Apondi R, Bunnell R, Ekwaru JP., et al. Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up. AIDS. 2011;25:1317-1327
37. Cornman DH, Kiene SM, Christie S., et al. Clinic-based intervention reduces unprotected sexual behavior among HIV-infected patients in KwaZulu-Natal, South Africa: results of a pilot study. JAIDS. 2008;48: 553-560
38. da Silveria MF, dos Santos IS. Impact of an educational intervention to promote condom use among the male partners of HIV-positive women. J Eval Clin Pract. 2006;12:102-111
39. Jones DL, Weiss SM, Bhat GJ., et al. Influencing sexual practices among HIV-positive Zambian women. AIDS Care. 2006;18:629-634
40. Jones DL, Ross D, Weiss SM., et al. Influence of partner participation on sexual risk behavior reduction among HIV-positive Zambian women. J Urban Health. 2005;82:92-99
41. Lightfoor MA, Kasirye R, Comulada WS., et al. Efficacy of a culturally adapted intervention for youth living with HIV in Uganda. Prev Sci. 2007;8:271-273
42. Papas RK, Sidle JE, Gakinya BN., et al. Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya. Addiction. 2011;106:2156-2166
43. Peltzer K, Tabane C, Matseke G., et al. Lay counsellor-based risk reduction intervention with HIV-positive diagnosed patients at public HIV counseling and testing sites in Mpumalanga, South Africa. Eval Program Plann. 2010;33:379-385
44. Rongkavilit C, Naar-King S, Wang B., et al. Motivational interviewing targeting risk behaviors for youth living with HIV in Thailand. AIDS Behav. 2013;17:2063-2074
45. Farquhar C, Kiarie JN, Richardson BA., et al. Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr. 2004;37:1620-1626
46. Kalembo FW, Zgambo M, Mulaga AN., et al. Association between male partner involvement and the uptake of prevention of mother-to-child transmission of HIV (PMTCT) interventions in Mwanza district, Malawi: a retrospective cohort study. PLoS One. 2013;8:e66517
47. Kaaya SF, Blander J, Antelman G., et al. Randomized controlled trial evaluating the effect of an interactive group counseling intervention for HIV-positive women on prenatal depression and disclosure of HIV status. AIDS Care. 2013;25:854-862
48. Semrau K, Kuhn L, Vwalika C., et al. Women in couples antenatal HIV counseling and testing are not more likely to report adverse social events. AIDS. 2005;19:603-609
49. Aluisio A, Richardson B, Bosire R., et al. Male antenatal attendance and HIV testing are associated with decreased infant HIV infection and increased HIV-free survival. JAIDS. 2010;56:76-82
50. Becker S, Mlay R, Schwandt H., et al. Comparing couples' and individual voluntary counseling and testing for HIV at antenatal clinics in Tanzania: a randomized trial. AIDS Behav. 2010;14:558-566
51. Brown LB, Miller W, Kamanga G., et al. HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention. JAIDS. 2011;56:437-442
52. Conkling M, Shutes EL, Karita E., et al. Couples' voluntary counseling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort study. J Int AIDS Soc. 2010;13:10
53. Henley C, Forgwei G, Welty T., et al. Scale-up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries. Sex Transm Dis. 2013;40:909-914
54. Kairania R, Gray RH, Kiwanuka N., et al. Disclosure of HIV results among discordant couples in Rakai, Uganda: a facilitated couple counselling approach. AIDS Care. 2010;22:1041-1051
55. Lugada E, Levin J, Abang B., et al. Comparison of home and clinicbased HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. JAIDS. 2010;55:245-252
56. Msuya SE, Mbizvo EM, Hussain A., et al. Low male partner participation in antenatal HIV counselling and testing in northern Tanzania: implications for preventive programs. AIDS Care. 2008;20: 700-709
57. Were WA, Mermin JH, Wamai N., et al. Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr. 2006;43:91-95
58. Rosenberg NE, Pettifor AE, De Bruyn G., et al. HIV testing and counseling leads to immediate consistent condom use among South African stable HIV-discordant couples. JAIDS. 2012;62:226-233
59. Skogmar S, Shakely D, Lans M., et al. Effect of antiretroviral treatment and counselling on disclosure of HIV-serostatus in Johannesburg, South Africa. AIDS Care. 2006;18:725-730
60. Stringer EM, Kaseba C, Levy J., et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007;197:144.e1-144.e8
61. Baumgartner JN, Green M, Weaver MA., et al. Integrating family planning services into HIV care and treatment clinics in Tanzania: evaluation of a facilitated referral model. Health Policy Plan. 2014;29 (5):570-9
62. Grossman D, Onono M, Newmann SJ., et al. Integration of family planning services into HIV care and treatment in Kenya: a clusterrandomized trial. AIDS. 2013;27(suppl 1):S77-S85
63. Haddad L, Wall KM, Vwalika B., et al. Contraceptive discontinuation and switching among couples receiving integrated HIV and family planning services in Lusaka, Zambia. AIDS. 2013;27(suppl 1):S93-S103
64. Hoke T, Harries J, Crede S., et al. Expanding contraceptive options for PMTCT clients: a mixed methods implementation study in Cape Town, South Africa. Reprod Health. 2014;11:3
65. Kosgei RJ, Lubano KM, Shen C., et al. Impact of integrated family planning and HIV care services on contraceptive use and pregnancy outcomes: a retrospective cohort study. J Acquir Immune Defic Syndr. 2011;58:e121-e126
66. Mark K, Menizen-Derr J, Stephenson R., et al. Contraception among HIV concordant and discordant couples in Zambia: a randomized controlled trial. J Women's Health (Larchmt). 2007;16:1200-1210
67. McCarraher DR, Vance G, Gwarzo U., et al. Changes in contraceptive use following integration of family planning into ART Services in Cross River State, Nigeria. Stud Fam Plann. 2011;42:283-290
68. Ngure K, Heffron R, Mugo N., et al. Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial. AIDS. 2009;23(suppl 1):S89-S95
69. Sarnquist CC, Moyo P, Stranix-Chibanda L., et al. Integrating family planning and prevention of mother to child HIV transmission in Zimbabwe. Contraception. 2014;89:209-214
70. Stephenson R, Vwalika B, Greenberg L., et al. A randomized controlled trial to promote long-term contraceptive use among HIV-serodiscordant and concordant positive couples in Zambia. J Women's Health (Larchmt). 2011;20:567-574
71. Wall KM, Vwalika B, Haddad L., et al. Impact of long-term contraceptive promotion on incident pregnancy: a randomized controlled trial among HIV-positive couples in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2013;63:86-95
72. Balkus JE, Richardson BA, Mochache V., et al. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIVseronegative women. Sex Transm Dis. 2013;40:499-505
73. Celum C, Wald A, Lingappa J., et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010;362:427-439
74. Dionne-Odom J, Karita E, Kilembe W., et al. Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda. Clin Infect Dis. 2013;56:1829-1837
75. Lingappa JR, Baeten JM, Wald A., et al. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet. 2010;375:824-833
76. Mayaud P, Nagot N, Konaté I, et al; ANRS 1285 Study Group. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Sex Transm Infect. 2008;84: 332-337
77. Paz-Bailey G, Sternberg M, Puren AJ., et al. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial. J Infect Dis. 2009;200:1039-1049
78. Phiri S, Hoffman IF, Weiss HA., et al. Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi. Sex Transm Infect. 2010;86:345-352
79. Reynolds SJ, Makumbi F, Newell K., et al. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, doubleblind placebo-controlled trial. Lancet Infect Dis. 2012;12:441-448
80. Roxby AC, Drake AL, Ongecha-Owuor F., et al. Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2. PLoS One. 2012;7:e38622
81. Wolday D, Gebremariam Z, Mohammed Z., et al. The impact of syndromic treatment of sexually transmitted diseases on genital shedding of HIV-1. AIDS. 2004;18:781-785
82. Anderson BL, Firnhaber C, Liu T., et al. Effect of trichomoniasis therapy on genital HIV viral burden among African women. Sex Transm Dis. 2012;39:638-642
83. Baeten JM, Strick LB, Lucchetti A., et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis. 2008;198:1804-1808
84. Delany S, Mlaba N, Clayton T., et al. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS. 2009;23:461-469
85. Drake AL, Roxby AC, Ongecha-Owuor F., et al. Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial. J Infect Dis. 2012;205:366-375
86. Kim HN, Wang J, Hughes J., et al. Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection. J Infect Dis. 2010;202:734-738
87. Masese LN, Graham SM, Gitau R., et al. A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy. BMC Infect Dis. 2011;11:307
88. Mayaud P, Legoff J, Weiss HA., et al. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial. J Infect Dis. 2009;200: 216-226
89. Mugwanya K, Baeten JM, Mugo NR., et al. High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial. J Infect Dis. 2011; 204:1912-1917
90. Nagot N, Ouédraogo A, Foulongne V., et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med. 2007;356:790-799
91. Zuckerman RA, Lucchetti A, Whittington WL., et al. HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men. AIDS. 2009;23:479-483
92. Zuckerman RA, Lucchetti A, Whittington WL., et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis. 2007;196: 1500-1508
93. Nachega JB, Leisegang R, Bishai D., et al. Association of antiretroviral therapy adherence and health care costs. Ann InternMed. 2010;152:18-25
94. Osoti AO, John-Stewart G, Kiarie J., et al. Home visits during pregnancy enhance male partner HIV counseling and testing in Kenya: a randomized clinical trial. AIDS. 2014;28:95-103
95. John FN, Farquhar C, Kiarie JN., et al. Cost effectiveness of couple counselling to enhance infant HIV-1 prevention. Int J STD AIDS. 2008; 19:406-409
96. Armbruster B, Helleringer S, Kohler HP., et al. Exploring the relative costs of contact tracing in increasing HIV case-finding in sub-Saharan countries: the case of Likoma Island (Malawi). JAIDS. 2011;58:e29-e36
97. Rutstein SE, Brown LB, Biddle AK., et al. Cost-effectiveness of provider-based HIV partner notification in urban Malawi. Health Policy Plan. 2014;29:115-126
98. Halperin DT, Stover J, Reynolds HW. Benefits and costs of expanding access to family planning programs to women living with HIV. AIDS. 2009;23(suppl 1):S123-S130
99. Shade SB, Kevany S, Onono M., et al. Cost, cost-efficiency and costeffectiveness of integrated family planning and HIV services. AIDS. 2013;27(suppl 1):S87-S92
100. Vickerman P, Devine A, Foss AM., et al. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa. Sex Transm Dis. 2011;38:401-409
101. Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011;87:183-190
102. Simoni J, Pearson C, Pantalone D., et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. JAIDS. 2006;43(suppl 1):S23-S35
103. Farley TM, Lusti-Narasimhan M. Hormonal contraception and risk of HIV acquisition: a difficult policy position in spite of incomplete evidence. Reprod Health Matters. 2012;20(39 suppl):41-47
104. Curtis KM, Nanda K, Kapp N. Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS. 2009;23(suppl 1):S55-S67
105. Phillips SJ, Curtis KM, Polis CB. Effect of hormonal contraceptive methods on HIV disease progression: a systematic review. AIDS. 2013; 27:787-794
106. Polis CB, Phillips SJ, Curtis KM. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS. 2013;27:493-505
107. President's Emergency Plan for AIDS Relief (PEPFAR). Drug Interactions Between Hormonal Contraceptive Methods and Antiretroviral Medications Used to Treat HIV. Washington DC. 2014. Available at: http://www.usaid.gov/sites/default/files/documents/1864/HC-ART-Brief.pdf
108. Polis CB, Phillips SJ, Curtis KM., et al. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception. 2014;90:360-390
109. World Health Organization. Hormonal Contraception and HIV: Technical Statement. Geneva, Switzerland. 2012. Available at: http://www.who. int/reproductivehealth/publications/family-planning/rhr-12-8/en/